An inexpensive drug already in use for other diseases might hold the key to a completely new way of treating cancers — not by killing off cancer cells, but by simply reprogramming them.
The finding comes from some exciting Canadian research on patients with brain tumours. The study found that DCA — or dichloroacetate — can shrink the tumours by altering a cancer cell’s metabolism.
While the study was small — just five patients were studied, the researchers say their findings are “proof in principle” that the treatment approach works. Read more…
